SC 13G

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. ___)*

 

 

Tricida, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

89610F101

(CUSIP Number)

March 16, 2022

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

 

Rule 13d-1(b)

 

 

Rule 13d-1(c)

 

 

Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 89610F101

 

 

  1.    

  Names of Reporting Persons

 

  Frazier Life Sciences Public Fund, L.P.

  2.  

  Check the Appropriate Box if a Member of a Group (see instructions)

  (a)  ☐        (b)  ☒

 

  3.  

  SEC USE ONLY

 

  4.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

   5.     

  Sole Voting Power

 

  0 shares

   6.   

  Shared Voting Power

 

  3,582,093 shares (1)

   7.   

  Sole Dispositive Power

 

  0 shares

   8.   

  Shared Dispositive Power

 

  3,582,093 shares (1)

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  3,582,093 shares (1)

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row 9

 

  6.3% (2)

12.  

  Type of Reporting Person (see instructions)

 

  PN

 

(1)

Consists of (i) 2,082,093 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P.

(2)

Based on (i) 55,424,875 shares of Common Stock outstanding on May 6, 2022 as set forth in the Issuer’s Form 10-Q as filed with the SEC on May 10, 2022 and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022.


CUSIP No. 89610F101

 

 

  1.    

  Names of Reporting Persons

 

  FHMLSP, L.P.

  2.  

  Check the Appropriate Box if a Member of a Group (see instructions)

  (a)  ☐        (b)  ☒

 

  3.  

  SEC USE ONLY

 

  4.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

   5.     

  Sole Voting Power

 

  0 shares

   6.   

  Shared Voting Power

 

  3,582,093 shares (1)

   7.   

  Sole Dispositive Power

 

  0 shares

   8.   

  Shared Dispositive Power

 

  3,582,093 shares (1)

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  3,582,093 shares (1)

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row 9

 

  6.3% (2)

12.  

  Type of Reporting Person (see instructions)

 

  PN

 

(1)

Consists of (i) 2,082,093 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P.

(2)

Based on (i) 55,424,875 shares of Common Stock outstanding on May 6, 2022 as set forth in the Issuer’s Form 10-Q as filed with the SEC on May 10, 2022 and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022.


CUSIP No. 89610F101

 

 

  1.    

  Names of Reporting Persons

 

  FHMLSP, L.L.C.

  2.  

  Check the Appropriate Box if a Member of a Group (see instructions)

  (a)  ☐        (b)  ☒

 

  3.  

  SEC USE ONLY

 

  4.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

   5.     

  Sole Voting Power

 

  0 shares

   6.   

  Shared Voting Power

 

  3,582,093 shares (1)

   7.   

  Sole Dispositive Power

 

  0 shares

   8.   

  Shared Dispositive Power

 

  3,582,093 shares (1)

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  3,582,093 shares (1)

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row 9

 

  6.3% (2)

12.  

  Type of Reporting Person (see instructions)

 

  OO

 

(1)

Consists of (i) 2,082,093 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P.

(2)

Based on (i) 55,424,875 shares of Common Stock outstanding on May 6, 2022 as set forth in the Issuer’s Form 10-Q as filed with the SEC on May 10, 2022 and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022.


CUSIP No. 89610F101

 

 

  1.    

  Names of Reporting Persons

 

  James N. Topper

  2.  

  Check the Appropriate Box if a Member of a Group (see instructions)

  (a)  ☐        (b)  ☒

 

  3.  

  SEC USE ONLY

 

  4.  

  Citizenship or Place of Organization

 

  United States Citizen

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

   5.     

  Sole Voting Power

 

  0 shares

   6.   

  Shared Voting Power

 

  3,582,093 shares (1)

   7.   

  Sole Dispositive Power

 

  0 shares

   8.   

  Shared Dispositive Power

 

  3,582,093 shares (1)

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  3,582,093 shares (1)

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row 9

 

  6.3% (2)

12.  

  Type of Reporting Person (see instructions)

 

  IN

 

(1)

Consists of (i) 2,082,093 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P.

(2)

Based on (i) 55,424,875 shares of Common Stock outstanding on May 6, 2022 as set forth in the Issuer’s Form 10-Q as filed with the SEC on May 10, 2022 and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022.


CUSIP No. 89610F101

 

  1.    

  Names of Reporting Persons

 

  Patrick J. Heron

  2.  

  Check the Appropriate Box if a Member of a Group (see instructions)

  (a)  ☐        (b)  ☒

 

  3.  

  SEC USE ONLY

 

  4.  

  Citizenship or Place of Organization

 

  United States Citizen

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

   5.     

  Sole Voting Power

 

  0 shares

   6.   

  Shared Voting Power

 

  3,582,093 shares (1)

   7.   

  Sole Dispositive Power

 

  0 shares

   8.   

  Shared Dispositive Power

 

  3,582,093 shares (1)

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  3,582,093 shares (1)

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row 9

 

  6.3% (2)

12.  

  Type of Reporting Person (see instructions)

 

  IN

 

(1)

Consists of (i) 2,082,093 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P.

(2)

Based on (i) 55,424,875 shares of Common Stock outstanding on May 6, 2022 as set forth in the Issuer’s Form 10-Q as filed with the SEC on May 10, 2022 and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022.


CUSIP No. 89610F101

 

  1.    

  Names of Reporting Persons

 

  Albert Cha

  2.  

  Check the Appropriate Box if a Member of a Group (see instructions)

  (a)  ☐        (b)  ☒

 

  3.  

  SEC USE ONLY

 

  4.  

  Citizenship or Place of Organization

 

  United States Citizen

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

   5.     

  Sole Voting Power

 

  0 shares

   6.   

  Shared Voting Power

 

  3,582,093 shares (1)

   7.   

  Sole Dispositive Power

 

  0 shares

   8.   

  Shared Dispositive Power

 

  3,582,093 shares (1)

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  3,582,093 shares (1)

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row 9

 

  6.3% (2)

12.  

  Type of Reporting Person (see instructions)

 

  IN

 

(1)

Consists of (i) 2,082,093 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P.

(2)

Based on (i) 55,424,875 shares of Common Stock outstanding on May 6, 2022 as set forth in the Issuer’s Form 10-Q as filed with the SEC on May 10, 2022 and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022.


CUSIP No. 89610F101

 

  1.    

  Names of Reporting Persons

 

  James Brush

  2.  

  Check the Appropriate Box if a Member of a Group (see instructions)

  (a)  ☐        (b)  ☒

 

  3.  

  SEC USE ONLY

 

  4.  

  Citizenship or Place of Organization

 

  United States Citizen

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

   5.     

  Sole Voting Power

 

  0 shares

   6.   

  Shared Voting Power

 

  3,582,093 shares (1)

   7.   

  Sole Dispositive Power

 

  0 shares

   8.   

  Shared Dispositive Power

 

  3,582,093 shares (1)

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  3,582,093 shares (1)

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row 9

 

  6.3% (2)

12.  

  Type of Reporting Person (see instructions)

 

  IN

 

(1)

Consists of (i) 2,082,093 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P.

(2)

Based on (i) 55,424,875 shares of Common Stock outstanding on May 6, 2022 as set forth in the Issuer’s Form 10-Q as filed with the SEC on May 10, 2022 and (ii) 1,500,000 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to a warrant exercisable within 60 days of March 16, 2022.


Item 1(a).    Name of Issuer: Tricida, Inc.
Item 1(b).    Address of Issuer’s Principal Executive Offices: 7000 Shoreline Court, Suite 201, South San Francisco, CA 94080
Item 2(a).   

Name of Person Filing:

 

The entities and persons filing this statement (collectively, the “Reporting Persons”) are:

 

Frazier Life Sciences Public Fund, L.P. (“FLSPF”)

FHMLSP, L.P.

FHMLSP, L.L.C.

James N. Topper (“Topper”)

Patrick J. Heron (“Heron”)

Albert Cha (“Cha”)

James Brush (“Brush” and together with Topper, Heron and Cha, the “Members”)

Item 2(b).   

Address of Principal Business Office or, if none, Residence:

 

The address and principal business office of the Reporting Persons is:

 

c/o Frazier Healthcare Partners

601 Union Street, Suite 3200

Seattle, Washington 98101

 

Item 2(c).    Citizenship:      
   Entities:    FLSPF    -     Delaware, U.S.A.
      FHMLSP, L.P.    -     Delaware, U.S.A.
      FHMLSP, L.L.C.    -     Delaware, U.S.A.
   Individuals:    Topper    -     United States Citizen
      Heron    -     United States Citizen
      Cha    -     United States Citizen
      Brush    -     United States Citizen

 

Item 2(d).    Title of Class of Securities: Common Stock
Item 2(e).    CUSIP Number: 89610F101
Item 3.    If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
(a)    ☐ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
(b)    ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)    ☐ Insurance company as defined in section 3(a)19) of the Act (15 U.S.C. 78c);
(d)    ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)    ☐ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)    ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)    ☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h)    ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)   

☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)    ☐ A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
(k)    ☐ Group, in accordance with §240.13d–1(b)(1)(ii)(K).
   If filing as a non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J), please specify the type of institution: ____


Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the Issuer identified in Item 1.

 

  (a)

Amount Beneficially Owned: See Row 9 of cover page for each Reporting Person.

  (b)

Percent of Class: See Row 11 of cover page for each Reporting Person

  (c)

Number of shares as to which the person has:

 

  (i)

Sole power to vote or to direct the vote: See Row 5 of cover page for each Reporting Person.

 

  (ii)

Shared power to vote or to direct the vote: See Row 6 of cover page for each Reporting Person.

 

  (iii)

Sole power to dispose or to direct the disposition of: See Row 7 of cover page for each Reporting Person.

 

  (iv)

Shared power to dispose or to direct the disposition of: See Row 8 of cover page for each Reporting Person.

 

Item 5.

Ownership of 5 Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐.

 

Item 6.

Ownership of More than 5 Percent on Behalf of Another Person

Not applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group

Each member of the group is identified on Exhibit A to this Schedule 13G.

 

Item 9.

Notice of Dissolution of a Group

Not applicable.

 

Item 10.

Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: May 16, 2022    FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.
   By: FHMLSP, L.P., its General Partner
   By: FHMLSP, L.L.C., its General Partner
   By:   

/s/ Steve R. Bailey

      Steve R. Bailey, Chief Financial Officer
Date: May 16, 2022    FHMLSP, L.P.
   By: FHMLSP, L.L.C., its General Partner
   By:   

/s/ Steve R. Bailey

      Steve R. Bailey, Chief Financial Officer
Date: May 16, 2022    FHMLSP, L.L.C.
   By:   

/s/ Steve R. Bailey

      Steve R. Bailey, Chief Financial Officer
Date: May 16, 2022    By:   

*

      James N. Topper
Date: May 16, 2022    By:   

*

      Patrick J. Heron
Date: May 16, 2022    By:   

**

      Albert Cha
Date: May 16, 2022    By:   

**

      James Brush
Date: May 16, 2022    By:   

/s/ Steve R. Bailey

      Steve R. Bailey, as Attorney-in-Fact

 

*

This Schedule 13G was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016.

**

This Schedule 13G was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021.


Exhibit Index

Exhibit A - Agreement regarding filing of joint Schedule 13G.

 

EX-A

EXHIBIT A

AGREEMENT

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Tricida, Inc.

 

Date: May 16, 2022    FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.
   By: FHMLSP, L.P., its General Partner
   By: FHMLSP, L.L.C., its General Partner
   By:   

/s/ Steve R. Bailey

      Steve R. Bailey, Chief Financial Officer
Date: May 16, 2022    FHMLSP, L.P.
   By: FHMLSP, L.L.C., its General Partner
   By:   

/s/ Steve R. Bailey

      Steve R. Bailey, Chief Financial Officer
Date: May 16, 2022    FHMLSP, L.L.C.
   By:   

/s/ Steve R. Bailey

      Steve R. Bailey, Chief Financial Officer
Date: May 16, 2022    By:   

*

      James N. Topper
Date: May 16, 2022    By:   

*

      Patrick J. Heron
Date: May 16, 2022    By:   

**

      Albert Cha
Date: May 16, 2022    By:   

**

      James Brush
Date: May 16, 2022    By:   

/s/ Steve R. Bailey

      Steve R. Bailey, as Attorney-in-Fact

 

*

This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016.

**

This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021.